MHRA (UK)
OTHER
Field Safety Notices: 13 to 17 July 2026
Published: 8/18/2026Detected: 7/21/2026
Summary preview
Field Safety Notices issued between 13 and 17 July 2026 indicate MHRA communications to support risk awareness and corrective actions for specific product safety issues.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountsafety
labeling
clinical
quality
manufacturing
#MHRA
#Field Safety Notice
#pharmacovigilance
#medical devices
#risk management
Official Source Document Source Verified
Access the original document directly from MHRA.
More from MHRA (UK)
- Class 4 Medicines Defect Notification: Neuraxpharm UK Limited, Levetiracetam Neuraxpharm granules for oral solution in sachet, EL(26)A/4010/1/2026
- Field Safety Notices: 21 to 25 September 20269/29/2026
- MHRA Safety Roundup: September 20269/29/2026
- Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/399/23/2026
- Field Safety Notices: 14 to 18 September 20269/23/2026